Chonluten
Also known as: T-34, EDG peptide, Glu-Asp-Gly, Bronchogen
Chonluten is a synthetic tripeptide (Glu-Asp-Gly, EDG) short-peptide bioregulator developed by Vladimir Khavinson and colleagues at the St. Petersburg Institute of Bioregulation and Gerontology. It targets the bronchopulmonary system, where the Khavinson group reports it modulates gene expression in respiratory epithelium via direct peptide-DNA interaction in promoter regions. Evidence is limited to preclinical and small clinical studies from a single Russian research group; it is not FDA-approved and has no Western clinical validation.
Who's worth your money for Chonluten
Every current seller, ranked by independent evidence — Merit Score, latest COA purity, and live $/mg (size-normalized). Prices refresh daily. Rankings are never paid.
Top Merit pick
Highest Merit Score (96) of 3 scored sellers
$69.97 · 20mg · 99.3% purity
Best value
Lowest $/mg among scored sellers
$50.00 · 20mg
Average price
$2.58/mg
Sellers
9
45-day trend
-9.8%
8 of 9 sellers have a current price· 5 unverified hidden
Top Merit pick
🇺🇸 BioLongevity Labs96via Disclosed Labs · 23h ago
$3.50/mg +35.6% vs avg$69.97
20mg
- 🇺🇸 Peptide Plugs89
✓ verified at source · 23h ago
$2.50/mg -3.1% vs avg$50.00
20mg
no purity - 🇺🇸 Verified Peptides86
via Disclosed Labs · 23h ago
$2.75/mg +6.6% vs avg$55.00
20mg
no purity
Prices observed from public storefronts (last 24h), normalized to $/mg. "Evidence" is Merit's 0–100 Merit Score, derived only from observable verification evidence (methodology on /about); "Purity" is the latest independent COA. Some buy links are affiliate links — Merit may earn a commission at no extra cost to you, and where a vendor offers one, the code shown gets you a discount at their checkout. Affiliate status never affects price data, ranking, or the Merit Score (full policy on /disclosure). Research use only.
Watch Chonluten
Get one email when the market actually moves — no newsletter, no noise.
About Chonluten
CAS
75007-24-8
Molecular formula
C11H17N3O8
Sequence
EDG
Typical dose range
No established clinical dosing; vendor research protocols commonly cite 1-2 mg/day subcutaneous or sublingual
Half-life
Not characterized in peer-reviewed pharmacokinetic literature; short-peptide bioregulators are presumed to clear rapidly (minutes)
Common research uses
Safety notes
Not FDA-approved for human therapeutic use. A Russian/Khavinson research peptide with little independent Western safety or efficacy data; sold grey-market for research use only. Not evaluated by WADA.
Reconstitution
Reconstitute lyophilized powder with bacteriostatic water; refrigerate after reconstitution.
COAs for Chonluten
3 third-party tests across 1 vendor. Each card links to the full report.
For
Chonluten
by Kimera Chems· batch KC-CLT-YET1
For
Chonluten
by BioLongevity Labs
Purity not on file
For
Chonluten
by BioLongevity Labs· batch 37-3-45777
3 citations indexed for Chonluten
Study · 2022
Peptides Regulating Proliferative Activity and Inflammatory Pathways in the Monocyte/Macrophage THP-1 Cell Line
This study evaluates the effects of five different peptides, the Epitalon ® tetrapeptide, the Vilon ® dipeptide, the Thymogen ® dipeptide, the Thymalin ® peptide complex, and the Chonluten ® tripeptide, as regulators of inflammatory and proliferative processes in the human monocytic THP-1, which is a human leukemia mon…
review · 2022
Transport of Biologically Active Ultrashort Peptides Using POT and LAT Carriers
Ultrashort peptides (USPs), consisting of 2-7 amino-acid residues, are a group of signaling molecules that regulate gene expression and protein synthesis under normal conditions in various diseases and ageing. USPs serve as a basis for the development of drugs with a targeted mechanism of action.
review · 2020
Peptides: Prospects for Use in the Treatment of COVID-19
There is a vast practice of using antimalarial drugs, RAS inhibitors, serine protease inhibitors, inhibitors of the RNA-dependent RNA polymerase of the virus and immunosuppressants for the treatment of the severe form of COVID-19, which often occurs in patients with chronic diseases and older persons.
Research use only — not for human consumption and not approved by the FDA. Nothing here is medical advice.